share_log

10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference

10x Genomics to Present at the 44th Annual TD Cowen Health Care Conference

10x Genomics 将在第 44 届年度道明考恩医疗保健会议上发表演讲
PR Newswire ·  02/20 16:05

PLEASANTON, Calif., Feb. 20, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its management team will participate in a fireside chat at the 44th Annual TD Cowen Health Care Conference on Tuesday, March 5, at 2:50 p.m. Eastern Time.

加利福尼亚州普莱森顿,2024年2月20日 /PRNewswire/ — 单细胞和空间生物学领域的领导者10x Genomics, Inc.(纳斯达克股票代码:TXG)今天宣布,其管理团队成员将参加44号的炉边谈话第四 年度TD Cowen医疗保健会议将于美国东部时间3月5日星期二下午 2:50 举行。

Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: The webcast will be archived and available for replay for at least 45 days after the event.

有兴趣的人士可以在公司网站的 “投资者” 栏目上观看炉边谈话的网络直播,网址为:该网络直播将在活动结束后至少45天内存档并可供重播。

About 10x Genomics

大约 10 倍基因组学

10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn or X (Twitter).

10x Genomics是一家生命科学技术公司,其产品旨在加速对生物学的掌握并促进人类健康。我们的综合解决方案包括用于单细胞和空间生物学的仪器、耗材和软件,可帮助学术和转化研究人员以及生物制药公司以与生物学复杂性相匹配的分辨率和规模了解生物系统。我们的产品是肿瘤学、免疫学、神经科学等领域取得突破的推动力,推动了改变世界对健康和疾病的理解的强大发现。要了解更多信息,请访问 10xgenomics.com 或通过 LinkedIn 或 X(Twitter)联系我们。

Disclosure Information

披露信息

10x Genomics uses filings with the Securities and Exchange Commission, our website (), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.

10x Genomics使用向美国证券交易委员会提交的文件、我们的网站 ()、新闻稿、公开电话会议、公开网络直播和我们的社交媒体账户作为披露重大非公开信息的手段,并用于履行我们在FD法规下的披露义务。

Contacts

联系人

Investors: [email protected]

投资者: [电子邮件保护]

Media: [email protected]

媒体: [电子邮件保护]

SOURCE 10x Genomics, Inc

来源 10x Genomics, Inc

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发